The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Over the counter (OTC) medicines (10)
- (-) Weight loss products (1)
- Alert/Advisory (97)
- Medicine safety (56)
- Safety (48)
- Medical devices safety (29)
- Regulatory compliance (22)
- Import and export (18)
- Prescription medicines (15)
- Listed medicines (12)
- Therapeutic goods regulation (12)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Shortages (9)
- Complementary medicines (7)
- Non-prescription medicines (6)
- Advertising (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Compliance and enforcement hub (1)
- Registered complementary medicines (1)
Search
11 result(s) found, displaying 1 to 11
-
Safety alertsFurther examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.
-
Market actionsCaruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.
-
Safety alertsThe oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
Safety alertsWe have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
-
Safety alertsThe TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).
-
Safety alertsRead our safety advisory for Medicines containing Withania somnifera (Withania, Ashwagandha). Be aware of potential gastrointestinal symptoms and very rare cases of liver injury.
-
Market actionsKin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.
-
Safety alertsThe TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.
-
Market actionsBioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.
-
Market actionsThe TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.
-